Ichikawa et al. investigated the relationship between hepatic fibrosis and serum levels of IGF-1, IGFBP-3, and GH in 55 patients (20 males and 35 females) with NAFLD. Here, IGFBP3 is linked to metabolic dysfunction-associated steatotic liver disease.